Understanding the Anticaries, Antiplaque Antigingivitis, and Hypersensitivity OTC Monographs: Creation, Status, and Impact
- Evan Howard
- May 7
- 8 min read
Oral health is a cornerstone of overall well-being, and millions of people rely on over-the-counter (OTC) products every day to prevent cavities, fight plaque and gingivitis, and manage tooth sensitivity. But have you ever wondered how these products are regulated, what standards they must meet, and how their safety and effectiveness are ensured without a prescription? The answer lies in the FDA’s OTC monograph system-a unique regulatory pathway that governs the ingredients, labeling, and claims for nonprescription oral care drugs. Explore the anticaries, antiplaque antigingivitis, and hypersensitivity OTC monographs: what they are, how they’re created, and their current status in the United States.
What Is an OTC Monograph?
An OTC monograph is essentially a “recipe book” for nonprescription drugs. It sets the rules for which active ingredients can be used, in what amounts, for which indications, and with what labeling and directions. If a product meets all the monograph’s requirements, it can be marketed without the need for a lengthy and expensive New Drug Application (NDA) process. This system streamlines access to safe and effective therapies, empowering consumers to manage common health conditions-including oral health-without a doctor’s visit.
Unlike prescription drugs, which are individually reviewed and approved based on clinical trial data, OTC monographs focus on the safety and effectiveness of active ingredients within a therapeutic class. As long as a product follows the monograph, it is considered “generally recognized as safe and effective” (GRASE) and can be sold directly to consumers.
The History and Evolution of OTC Monographs
The origins of the OTC monograph system date back to the early 1970s. At that time, the FDA recognized the need for a standardized way to evaluate the safety and effectiveness of the vast array of nonprescription drugs on the market. In 1972, the agency launched the first comprehensive OTC drug review. Advisory Review Panels were established to examine entire classes of drugs, categorizing ingredients as GRASE (Category I), not GRASE (Category II), or needing more data (Category III).
Over the decades, the monograph system has evolved, shaped by scientific advances, public health needs, and legislative reforms. A major milestone came with the passage of the CARES Act in 2020, which replaced the old rule making process with a more efficient administrative order system for updating and creating monographs. This change allows for faster responses to new safety information and streamlines the process for adding or modifying ingredients and claims.
How Are OTC Monographs Created?
The creation of an OTC monograph is a rigorous, multi-step process designed to ensure public safety and scientific integrity. Here’s how it works:
Initiation and Review: The FDA or industry stakeholders can propose the creation or revision of a monograph. This can be triggered by new scientific evidence, safety concerns, or requests to add new ingredients or indications.
Scientific Evaluation: The FDA reviews available scientific data, including clinical studies, toxicology reports, and real-world evidence. Advisory panels of experts may be convened to assess the data and make recommendations.
Public Participation: Proposed monographs are published for public comment, allowing input from manufacturers, healthcare professionals, consumer groups, and the general public. This transparency ensures a broad range of perspectives are considered.
Administrative Order Process: Under the CARES Act, changes to monographs are now made through administrative orders, which can be initiated by the FDA or by industry via an OTC Monograph Order Request (OMOR). The process includes a public comment period, after which the FDA issues a final order.
Implementation and Enforcement: Once finalized, the monograph becomes legally binding. Manufacturers must comply with its requirements for ingredients, dosages, labeling, and quality standards. The FDA monitors compliance through inspections, product sampling, and surveillance.
Components of an OTC Monograph
Each monograph is a detailed regulatory document that covers all aspects of a drug’s formulation, labeling, and use. Key components include:
Active Ingredients and Dosage: Specifies which ingredients are allowed, their concentrations, and acceptable dosage forms (e.g., toothpaste, mouthwash).
Indications and Claims: Defines the health claims that can be made (e.g., “helps prevent cavities” or “reduces plaque and gingivitis”).
Labeling Requirements: Outlines mandatory warnings, directions for use, and other information to ensure safe and effective use by consumers.
Testing and Quality Standards: May require specific tests for identity, strength, purity, and stability to ensure product quality.
Inactive Ingredients: Lists acceptable inactive ingredients and any limitations on their use.
Anticaries Monograph: Fighting Cavities
The anticaries monograph is one of the most well-established in the OTC oral care category. Its primary goal is to regulate products that help prevent dental caries (cavities), a common and costly public health problem.
Allowed Active Ingredients
The anticaries monograph permits several fluoride compounds as active ingredients, including sodium fluoride, stannous fluoride, and sodium monofluorophosphate. These ingredients are recognized for their ability to strengthen tooth enamel and make it more resistant to acid attacks from bacteria.
Dosage Forms and Claims
Products covered by the anticaries monograph include toothpastes, mouth rinses, and gels. The monograph specifies the allowable concentrations of fluoride and the precise claims that can be made, such as “aids in the prevention of dental cavities.” Products must also include specific warnings and directions to minimize the risk of fluoride overexposure, especially in children.
Current Status
The anticaries monograph is considered final and well-established, with decades of safe and effective use. Most fluoride-containing toothpastes and rinses on the market today are formulated in strict compliance with this monograph. Any new active ingredient or novel claim not covered by the monograph would require an NDA.
Antiplaque and Antigingivitis Monograph: Controlling Plaque and Gum Disease
Plaque and gingivitis are leading causes of oral health problems, including gum disease and tooth loss. The antiplaque and antigingivitis monograph governs OTC products that claim to reduce dental plaque and prevent or treat gingivitis.
Permitted Ingredients
The monograph allows several active ingredients, including stannous fluoride (which also appears in the anticaries monograph), cetylpyridinium chloride (CPC), and certain combinations of essential oils (such as eucalyptol, menthol, methyl salicylate, and thymol). These ingredients have demonstrated efficacy in reducing plaque and gingivitis when used as directed.
Dosage Forms, Claims, and Labeling
Permitted dosage forms include mouthwashes and toothpastes. The monograph specifies allowable concentrations, required labeling, and precise claims such as “helps control plaque that leads to gingivitis.” Products must also include warnings and directions to ensure safe use.
Current Status
The antiplaque and antigingivitis monograph is not yet finalized; it remains in a tentative final monograph (TFM) stage. However, products formulated in accordance with the TFM are generally allowed to remain on the market. The FDA continues to review data and may update the monograph as new evidence emerges. Notably, some ingredients previously used (like triclosan) are no longer permitted due to safety concerns.
Hypersensitivity Monograph: Relieving Tooth Sensitivity
Tooth sensitivity is a common complaint, affecting millions of adults. The hypersensitivity monograph regulates OTC products that claim to reduce or relieve sensitivity to hot, cold, sweet, or acidic foods and drinks.
Approved Ingredients
The main active ingredients allowed under the hypersensitivity monograph are potassium nitrate and strontium chloride. These agents work by calming the nerves inside the teeth or blocking the pathways that lead to sensitivity.
Dosage Forms and Claims
Products typically include toothpastes and gels. The monograph specifies the concentrations of active ingredients and the claims that can be made, such as “helps relieve sensitivity in teeth.” Labeling requirements include warnings about when to consult a dentist and directions for safe use.
Current Status
Like the antiplaque and antigingivitis monograph, the hypersensitivity monograph is still in a tentative stage. Products that comply with the TFM are generally considered GRASE and may remain on the market, but the FDA continues to monitor new data and may revise the monograph as needed.
The Monograph Pathway vs. New Drug Application (NDA)
It’s important to understand the difference between the monograph and NDA pathways. The NDA process is required for drugs that contain new active ingredients, novel combinations, or make claims not covered by an existing monograph. NDA drugs undergo rigorous clinical testing and FDA review before approval.
In contrast, the monograph pathway allows for faster, more cost-effective access to established therapies. As long as a product meets all monograph requirements, it can be marketed without individual FDA approval. This system helps keep oral care products affordable and widely available, while still ensuring safety and effectiveness.
How Are Monographs Updated or Changed?
The process for updating or changing an OTC monograph has become more efficient in recent years, thanks to legislative reforms like the CARES Act. Changes can be initiated by the FDA or by industry through an OTC Monograph Order Request (OMOR). The process involves:
Submission of scientific data to support the change
FDA review and publication of a proposed order
Public comment period (typically at least 45 days)
Issuance of a final administrative order
This process allows the FDA to respond more quickly to new safety information, scientific advances, or public health needs, while still maintaining transparency and public participation.
Compliance and Enforcement
Manufacturers of OTC oral care products must strictly adhere to the requirements of the relevant monograph. This includes using only permitted active ingredients at specified concentrations, following labeling and quality standards, and conducting appropriate testing. The FDA monitors compliance through facility inspections, product sampling, and adverse event reporting. Products that do not comply with the monograph may be subject to enforcement action, including recalls or removal from the market.
The Impact of OTC Monographs on Oral Health
The OTC monograph system has had a profound impact on public health by ensuring that safe, effective, and affordable oral care products are widely available. Consumers can trust that products like fluoride toothpaste, mouthwash for gingivitis, and sensitivity-relief toothpaste have been rigorously evaluated and meet high standards for safety and efficacy.
At the same time, the system allows for innovation and adaptation as new scientific evidence emerges. The streamlined administrative order process ensures that monographs can be updated efficiently, keeping pace with advances in oral health science and changing consumer needs.
The anticaries, antiplaque antigingivitis, and hypersensitivity OTC monographs form the backbone of oral care regulation in the United States. By establishing clear, science-based standards for ingredients, dosages, labeling, and claims, these monographs protect consumers and promote public health. The recent reforms to the monograph system have made it more responsive and efficient, ensuring that safe and effective oral care products remain accessible to all.
Whether you’re brushing to prevent cavities, rinsing to fight gum disease, or seeking relief from tooth sensitivity, you can be confident that the products you use are backed by decades of scientific research and robust FDA oversight. The monograph system is a testament to the power of evidence-based regulation in safeguarding the health and well-being of millions of Americans.
Howard Law is a business, regulatory and M&A law firm in the greater Charlotte, North Carolina area, with additional services in M&A advisory and business brokerage. Howard Law is a law firm based in the greater Charlotte, North Carolina area focused on business law, corporate law, regulatory law, mergers & acquisitions, M&A advisor and business brokerage. Handling all business matters from incorporation to acquisition as well as a comprehensive understanding in assisting through mergers and acquisition. The choice of a lawyer is an important decision and should not be based solely on advertisements. The information on this website is for general and informational purposes only and should not be interpreted to indicate a certain result will occur in your specific legal situation. Information on this website is not legal advice and does not create an attorney-client relationship. You should consult an attorney for advice regarding your individual situation. Contacting us does not create an attorney-client relationship. Please do not send any confidential information to us until such time as an attorney-client relationship has been established.
Comments